IN BRIEF: ConvaTec completes acquisition of wound care business Triad

ConvaTec Group PLC - Reading, England-based medical products and technologies company - Completes ...

Alliance News 14 March, 2022 | 10:18AM
Email Form Facebook Twitter LinkedIn RSS

ConvaTec Group PLC - Reading, England-based medical products and technologies company - Completes USD125 million acquisition of Triad Life Sciences Inc, a Memphis, Tennessee-based company focused on developing biological products for surgical wounds. Triad's portfolio and product pipeline will now be absorbed into ConvaTec's Advanced Wound Care business, and become known as ConvaTec Advanced Tissue Technology.

In the two years post-completion, there are two earnout payments conditional on Triad's performance, up to a maximum earnout of USD275 million.

Current stock price: 178.55 pence, up 1.3% on Monday

12-month change: down 7.0%

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
ConvaTec Group PLC 255.64 GBX -0.69

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures